Geisinger offering third-dose COVID-19 vaccines for immunocompromised people

DANVILLE, Pa. – Following recent guidance from the Food and Drug Administration, Geisinger is now offering third-dose COVID-19 vaccines for immunocompromised people. Third-dose vaccines are available by appointment at Geisinger Community Vaccine Centers or select Geisinger Pharmacy locations.

People eligible for the third dose are those who already received two doses of either the Pfizer BioNTech or Moderna mRNA COVID-19 vaccines and have weakened immune systems. According to the Centers for Disease Control and Prevention, this includes people who have: 

• Been receiving active cancer treatment for tumors or cancers of the blood
• Received an organ transplant and are taking medicine to suppress the immune system
• Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
• Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
• Advanced or untreated HIV infection
• Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response

If you are unsure if you’re eligible for a third dose of a COVID-19 vaccine, talk with your doctor. 

Make an appointment for a third-dose COVID-19 vaccine at Geisinger through MyGeisinger or by calling 570-284-3657. Appointments are available at the vaccine centers at the Geisinger Health Plan Building near Danville, Geisinger CenterPoint in Jenkins Township, Geisinger Jersey Shore Hospital and Geisinger Lewistown Hospital. Appointments are also available at Geisinger Pharmacy locations in Dallas, Danville, Lewistown, Lock Haven, Mount Pocono, Pottsville, State College and Scranton. 

Remember to bring the COVID-19 vaccine card or proof of having received both vaccine doses to the third-dose appointment. More information about the COVID-19 vaccine is available at geisinger.org/COVIDVax.

As a reminder, one visitor is permitted for outpatient appointments, and masks must be worn (regardless of COVID-19 vaccination status) by all patients, visitors and employees in all Geisinger buildings and facilities.

About Geisinger
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the non-profit system generates $10 billion in annual revenues across 134 care sites - including 10 hospital campuses, and Geisinger Health Plan, with 600,000 members in commercial and government plans. The Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and conducts more than 1,400 clinical research studies. With 26,000 employees, including 1,600 employed physicians, Geisinger is among Pennsylvania’s largest employers with an estimated economic impact of $14 billion to the state’s economy. On March 31, 2024, Geisinger became the first member of Risant Health, a new nonprofit charitable organization created to expand and accelerate value-based care across the country.  Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and X.